Yüklüyor......
β-Blocker Efficacy in High-Risk Patients with the Congenital Long-QT Syndrome Types 1 and 2: Implications for Patient Management
BACKGROUND: β-blockers are the mainstay therapy in patients with the congenital long-QT syndrome (LQTS) types 1 and 2. However, limited data exist regarding the efficacy and limitations of this form of medical management within high-risk subsets of these populations. METHODS AND RESULTS: Multivariat...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2010
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4005824/ https://ncbi.nlm.nih.gov/pubmed/20233272 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1540-8167.2010.01737.x |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|